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Methylation is an underpinning process of life and provides control for biologi-
cal processes such as DNA synthesis, cell growth, and apoptosis. Methionine
adenosyltransferases (MAT) produce the cellular methyl donor, S-Adenosyl-
methionine (SAMe). Dysregulation of SAMe level is a relevant event in many
diseases, including cancers such as hepatocellular carcinoma and colon cancer.
In addition, mutation of Arg264 in MATa1 causes isolated persistent hyperme-
thioninemia, which is characterized by low activity of the enzyme in liver and
high level of plasma methionine. In mammals, MATa1/a2 and MATbV1/V2
are the catalytic and the major form of regulatory subunits, respectively. A gat-
ing loop comprising residues 113–131 is located beside the active site of catalytic
subunits (MATa1/a2) and provides controlled access to the active site. Here, we
provide evidence of how the gating loop facilitates the catalysis and define some
of the key elements that control the catalytic efficiency. Mutation of several resi-
dues of MATa2 including Gln113, Ser114, and Arg264 lead to partial or total
loss of enzymatic activity, demonstrating their critical role in catalysis. The enzy-
matic activity of the mutated enzymes is restored to varying degrees upon com-
plex formation with MATbV1 or MATbV2, endorsing its role as an allosteric
regulator of MATa2 in response to the levels of methionine or SAMe. Finally,
the protein–protein interacting surface formed in MATa2:MATb complexes is
explored to demonstrate that several quinolone-based compounds modulate the
activity of MATa2 and its mutants, providing a rational for chemical design/in-
tervention responsive to the level of SAMe in the cellular environment.
Enzymes
Methionine adenosyltransferase (EC.2.5.1.6).
Database
Structural data are available in the RCSB PDB database under the PDB ID 6FBN (Q113A),
6FBP (S114A: P22121), 6FBO (S114A: I222), 6FCB (P115G), 6FCD (R264A), 6FAJ
(wtMATa2: apo), 6G6R (wtMATa2: holo)
Abbreviations
ADO, adenosine; ADP, adenosine diphosphate; AMP-PNP, adenylyl-imidodiphosphate; ATP, adenosine triphosphate; LcisAMB, L-2-amino-4-
methoxy-cis-but-3-enoic acid; MAT, methionine adenosyltransferase; Met, methionine; PPNP, (Diphosphono) aminophosphonic acid; PPPi,
tripolyphosphate; SAMe, S-Adenosylmethionine; SEC, size-exclusion chromatography; wt, wild-type.
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Introduction
A highly conserved family of Methionine adenosyl-
tranferases (MATs) produces S- Adenosylmethionine
(SAMe) from methionine (Met) via an ATP-driven
process [1,2]. MAT catalyzes two-step reactions: (a)
SAMe is formed via nucleophilic attack of sulfur atom
of methionine to C-50 atom of ATP and the
tripolyphosphate (PPPi) is generated as an intermedi-
ate of ATP cleavage; (b) PPPi is thus hydrolyzed to
pyrophosphate (PPi) and orthophosphate (Pi) by
tripolyphosphatase activity of MAT. SAMe donates
the methyl group to a variety of biomolecules includ-
ing amino acids, sugars, nucleotide bases of DNA and
RNA [3–5]. SAMe is an intracellular regulator of cel-
lular proliferation, differentiation, and death in liver
[6–8] and is involved in gene expression regulation [9,
10]. Decrease in SAMe results in abnormal cellular
methylation and reduction in antioxidant capacity [11].
In mammalian cells, MATa1 and MATa2 are two
variants of the catalytic subunit produced from
MAT1A and MAT2A gene, respectively. MATa1
functions as homo-dimer and tetramer[12,13], while
MATa2 forms an hetero-oligomer with the regulatory
subunit MATb (which has two predominant isoforms
differ in lengths, MATbV1 and MATbV2, 334 and
323 amino acids, respectively) in 2 : 1 ratio (MAT
(a2)4(bV1)2 or MAT(a2)4(bV2)2) [14,15]. MATa2 is
ubiquitously expressed in healthy cells, except in the
liver (mainly hepatocytes) where MATa1 is primarily
expressed, while colon and liver tumor cells ectopically
express high amounts of MATa2 [16–19] a switch that
promotes the proliferation of cancer cells [20–22].
Although SAMe can be produced by MATa2 alone,
the production of SAMe is increased several folds
when it complexes with MATb [14]. MATb interacts
with MATa2 through the insertion of the C-terminal
tail of the b subunit into a cavity created at the inter-
face of the MATa2 dimer. Comparison of the MATa2
and MATa2b complex structures revealed that the cat-
alytic site of MATa2 is unaltered upon complex for-
mation thus the increase in SAMe production in
MATa2b complex arises from factors beyond the cat-
alytic site through an allosteric regulation [23]. The
binding of MATb to MATa2 may propagate from the
MATb-binding site (Gln190-Ile198) to regions con-
necting the active and allosteric site (Ile241-Tyr271,
Gly272-Thr288), and the region (Ala109-Gly140) that
contains gating loop domain of MATa2 (Gln113-
Gly131). The substrate binding and product release
are likely linked to and modulated by MATb binding
to the MATa2 allosteric site offering the use of hetero-
dimeric interface as a target for chemical intervention:
either stabilization of defective enzymes or inhibition
of the overexpressed enzymes [24].
A gating loop, residue 113–131 in both MATa1 and
MATa2, has been identified in the catalytic subunits
of all MAT enzymes from prokaryotes to eukaryotes
[23, 25–30]. This loop is flexible and presumed to open
and close to allow or block access to the active site
[26, 31]. Recent crystallographic studies of MATa2
and MATa2b complex have shown that the gate is
open when active site is empty or occupied by PPNP
((Diphosphono)aminophosphonic acid) and is shut like
a lid when the active site is occupied by SAMe or ade-
nosine, demonstrating that the opening of the gate to
release product is not driven by hydrolysis of the
tripolyphosphate (PPPi) [14,23].
The majority of amino acid residues that participate
in catalysis are conserved in MAT enzymes across a
wide range of species, however, the enzyme kinetics of
MATs strongly depends on the source of protein [31–
34]. The composition of the gating loop varies across
species [31]. The influence of the length and sequence
of the loop on catalytic efficiency has been studied by
mutations of Escherichia coli MAT gating loop region
DRADPLEQ to fragment from rat liver loop
sequences (HDLRNEEDV), which resulted in decrease
of more than 200-fold in the maximal rate (Kcat) of
SAMe formation, with little effect on the rate of PPPi
hydrolysis [35]. The active site of MAT is formed at
the symmetric dimer interface by mainly hydrophobic
interactions except for Arg264 which is one of the few
polar residues at the interface. Mutation of Arg264 in
MATa1 (Arg264His/Cys) causes isolated persistent
hypermethioninemia, which is characterized by low
activity of the enzyme in liver and high level of plasma
methionine [36]. Most genetic mutations are inherited
as an autosomal recessive trait [37]; however, domi-
nant inheritances of hypermethioninemia have been
found in patients with the Arg264 (Arg264His/Cys)
and Ala259 (Ala259Val) mutations of MATa1 [36, 38,
39]. Arg264 facilitates dimerization by providing a pos-
itive charge to form salt bridge with Glu57 of the part-
ner subunit and interacts with Gly263 of the partner
subunit via K+ ion at the central region of dimer
interface to form the compact geometry of the active
site [40,41]. It has been hypothesized that the abro-
gated activity of Arg264His/Cys is a consequence of
an inability to establish a functional active site [42,43].
Here, we provide direct evidence that mutation does
not compromise the dimeric association but results in
the deprivation of an interaction at c-site of PPPi moi-
ety and the loss of the enzymatic activity in a manner
similar to Ser114 mutation, a residue that is part of
the gating loop. Ser114 coordinates the adenine ring of
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the substrate AMP-PNP (a nonhydrolysable analog of
ATP) via a water molecule and provides a rigid helix
conformation to the closed gating loop. Surprisingly
the mutation of Gln113, the only residue that interacts
with Met/SAMe directly, had little effect on the enzy-
matic activity, as loss of Gln113 does not seem to pre-
vent substrate Met from binding to the active site and
the orientation of Met is also preserved. Intriguingly,
the phosphatase activity for all of the mutants remains
the same as the wild-type enzyme. High-resolution
crystallographic structures of these mutants together
with detailed functional data establish the significance
of Ser114 as a sensor of substrate and product. We
also show that the loss in activity in Arg264Ala
mutant is not due to any compromise in dimer forma-
tion but is related to residue’s role in the interaction
with tripolyphosphate. We show that the enzymatic
activity of the mutated enzymes is restored upon com-
plexation with the regulatory protein MATb and have
harnessed this observation to find druggable quino-
lone-based compounds that may interact with the
interface region utilized in the formation of MATab
complex and restore the enzymatic activity.
Results and Discussion
Enzymatic and phosphatase activity
Using E. coli MAT, Kcat of SAMe formation has been
shown to decrease by more than 200-fold with muta-
tions in the gating loop without effecting the
tripolyphosphate hydrolysis rate [35]. Eighteen variants
of MATa1 mutation sites have been identified in
patients with persistent hypermethioninemia [44], seven
of these mutants (Arg249Trp, Ile252Thr, Gly257Arg,
Asp258Gly, Ala259Val, Lys289Ash, and Gly381Arg)
presented themselves with significantly lower levels of
SAMe indicating decreased activity, while their phos-
phatase activities were unaffected. Taken together,
these studies suggested that phosphatase activity is
independent on SAMe formation and the gating loop
has an important role in SAMe production which does
not affect the PPPi hydrolysis rate.
We explored functional significance of the conserved
residues (Gln113, Ser114, and Pro115) among the vari-
able regions of the gating loop using human MATa2
and generating a number of its mutants: Gln113Ala,
Ser114Ala, and Pro115Gly mutants. Pro is the only
amino acid that connects its side chain to backbone,
thus we mutated it to Gly which has no side chain as
well, while Gln (Q113) and Ser (S114) have movable
side chains and thus more suitable to mutate to Ala to
see the functional role of their side chain. We also
explored Arg264 residue’s role of MATa2 (Arg264Ala)
and MATa1 (Arg264His), the mutation of later being
mainly affecting to methionine metabolism in hepato-
cyte of liver and linked to inherited hypermethionine-
mia. We have shown recently that Gln113 and Ser114
residues interact with Met/SAMe in both the enzyme
on its own and when it complexes with MATb [14,
23]. Gln113Ala mutation results in 75.6  4.5% of
SAMe production while Ser114Ala mutation results in
near abolition of enzymatic activity to only
2.5  0.8% (p < 0.05) when compared to wtMATa2
(Fig. 1A). In contrast, Pro115Gly mutant has activity
similar to the wild-type enzyme (wtMATa2) (Fig. 1A).
MATa1 (Arg264His) and MATa2 (Arg264Ala) caused
major loss in enzymatic activity with SAMe production
reduced to 6.1  2.6% (p < 0.05) and 4.5  1.4%
(p < 0.05), respectively, compared to wtMATa1/2
(Fig. 1A).
Remarkably, the SAMe production is recovered in
Gln113Ala and Ser114Ala mutants when they complex
with either MATbV1 or MATbV2 to the extent that
the production of SAMe by Gln113Ala/Ser114Ala
MATa2:MATb complexes was the same as for the
wtMATa2:MATb complex confirming the regulatory
allosteric role of MATb (Fig. 1A). The SAMe produc-
tion by Arg264Ala MATa2 mutant also recovers upon
complexation but to the level of wtMATa2 on its own.
Surprisingly, none of the mutants show any change in
their phosphatase activities compared to the wtMATa2
(Fig. 1B) providing clear evidence that structural ele-
ments that control SAMe synthesis are different from
those involved in PPPi hydrolysis. MAT enzyme was
suggested to perform ATPase activity as an intrinsic
property that functions independently from SAMe syn-
thesis [29, 40]. The crystal structure of MATa1 in
complex with ADP (Adenosine diphosphate) was
derived from the cocrystallization of ATP (Adenosine
triphosphate) and methionine analog LcisAMB (L-2-
amino-4-methoxy-cis-but-3-enoic acid) confirming that
the hydrolysis of ATP could take place without SAMe
formation [25]. Complexation with MATbV1 generally
results in higher activity than when MATa2 or its
mutants complex with MATbV2. The amount of
SAMe produced by Arg264Ala is the same as the
wild-type when it complexes with either of the iso-
forms of MATb subunit, thus in this case the effect of
MATb regulatory subunit interaction on functional
recovery of Arg264Ala mutant is independent from
MATb lengths. These observations provide clear evi-
dence that interaction with MATb has a profound
effect on the catalytic activity of MAT enzyme where
the length of the MATb protein has a significant
impact on wild-type, Gln113Ala, Ser114Ala (Fig. 1)
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[45], suggesting that the interaction region may be a
candidate for intervention to control and regulate the
production of SAMe.
Crystallographic structures of apo, wild-type, and
mutant human MATa2 enzyme
Seven crystallographic structures are reported here
which include apo- and ligand-bound wtMATa2, gat-
ing loop MATa2 mutants (Gln113Ala, Ser114Ala, and
Pro115Gly: Q113A, S114A, and P115G, respectively)
and hypermethioninemia-associated Arg264Ala:
R264A mutant. All data collection and refinement
statistics are shown in Tables 1 and 2. Structure of
S114A mutant has been obtained in two different crys-
tallographic forms (I222 and P22121) while P115G,
R264A, and ligand-bound wtMATa2 crystals had I222
symmetry and Q113A, S114A, and apo-wtMATa2
crystallized in space group P22121. Two structures of
S114A are identical thus confirming that the detailed
structural observations are independent of the crystal
form and as such truly represent the molecular behav-
ior of the enzyme providing a rigorous basis for under-
lying mechanism. The intermediates and products
observed in the structures reported here differ
(Table 3), although the enzyme, in each case, was
incubated with the same substrates Met and AMP-
PNP (adenylyl-imidodiphosphate, a nonhydrolyzable
analog of ATP) prior to crystallization. SAMe is
observed in wtMATa2, Q113A, and P115G, all of
which have similar enzymatic activities (75–110% of
wtMATa2). SAMe is absent in structures of S114A
and R264A mutants which have less than 4% enzy-
matic activity fully consistent with the inability of
these mutants to perform the conversion of methionine
into SAMe.
Understanding hypermethioninemia and
potential therapeutic intervention
A number of pathogenic mutations have been identi-
fied in human MATa1 which result in the enzyme to
metabolize methionine less efficiently. This causes the
accumulation of methionine in the blood and in sev-
ere cases can develop neurological problems. These
sites are found to be conserved in both MATa1 and
MATa2. Some missense mutations are found at the
dimer interface, for example, Arg249Trp, Ile252Thr,
Gly257Arg, Ala259Val, and Arg264Cys/His. In partic-
ular, Arg264 forms a salt bridge with Glu57 of the
dimeric partner. Its substitution to a cysteine or his-
tidine residue almost completely abolished the enzy-
matic activity, which was hypothesized to arise from
an inability to dimerize [42, 43]. In the homologous
rat enzyme, replacement of the equivalent Arg265 by
His (R265H) resulted in a monomeric species with
only 0.4% of the SAMe synthetic activity [43]. In
contrast, we find that human Arg264His (R264H)
MATa1 and Arg264Ala (R264A) MATa2 mutants
are multimeric in solution. Two fractions of R264H
MATa1 eluted from size-exclusion chromatography
(SEC) correspond to tetramer and dimer, respectively,
while wtMATa1 and R264A MATa2 eluted primarily
as a single tetramer fraction (Fig. 2A). Equivalent
mutations (R244L/R244H) carried out in E. coli
MAT also showed a tetrameric assembly in solution
[46]. In addition, both R264H MATa1 and R264A
MATa2 are capable of forming a hetero-oligomer
with MATb as shown by analytical SEC for R264A
MATa2 in Fig. 2B. The complex formation has been
Fig. 1. Enzymatic and phosphatase activities of wild-type and
mutant enzymes. (A) SAMe formation of wtMATa1 and wtMATa2
compared to mutant enzymes (B) Phosphatase activity of wild-type
enzymes and complexes compared to mutant enzymes. (‘*’, ‘**’,
and ‘***’ denote statistical significance at P < 0.05, P < 0.01, and
P < 0.001 compared with wtMATa1/2, respectively). Data are
mean  SEM (n = 3).
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also confirmed by native and SDS/PAGE (Fig. 2C).
To establish the oligomeric state of the R264A
mutant in solution, small-angle X-ray scattering
(SAXS) data of purified R264A proteins were
obtained at the SEC-SAXS facility SWING at the
SOLEIL synchrotron. The SAXS data (Fig. 2D)
clearly showed dominant species to be a tetramer.
Although mutants of this residue in both MATa1
and MATa2 form a homo-dimer in solution, they
have no ability to produce SAMe without MATbV1/
V2 subunits, which are not coexpressed with MATa1
in the adult liver. The loss of activity caused by point
mutation in Arg264 residue can be recovered to
wtMATa2 level when R264A forms hetero-oligomer
with MATbV1/V2 (Fig. 1A). The observation that
the interaction with MATbV1/V2 can modulate and
restore function of the pathogenic mutant enzyme
activity offers possibility of chemical intervention in
finding therapeutic solutions using recently discovered
the effect of compounds with triazoloquinoline cores
on wtMATa2 [24].
We used the R264A MATa2 mutant as a model to
study the catalytic role of Arg264, which was con-
served among MATa1 and MATa2. Crystallization
of MATa1 has been problematic and attempts to
crystallize R264H MATa1 gave only low diffraction
quality crystals (the highest resolution we obtained
was 3 A, which is not sufficient to see atomic details).
We thus switched to R264A in MATa2, which dif-
fracted at high resolution (1.7A) with enzyme sub-
strate/product bound and well defined in the active
sites. This has allowed us to use the R264A structure
as the model to understand the functional role of
Arg264 in MAT enzyme. The crystallographic struc-
ture of R264A MATa2 revealed the presence of
ADO (occupancy, 1.0) and Pyrophosphate (PPi)
Table 1. Crystallographic data collection
and refinement statistics for wtMATa2
and its mutants Data collection Q113A P115A wtMATa2 (Apo)
wtMATa2
(Holo)
Space group P22121 I222 P22121 I222
Cell dimensions
a, b, c (A) 63.63, 103.93,
109.79
66.33, 94.87,
117.37
62.18, 103.23,
108.36
67.63, 94.00,
116.69
a, b, ϒ (A) 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90
Resolution (A) 103.93–2.70 54.36–2.70 74.74–1.95 73.20–1.35
(last shell) (A) (2.83–2.70) (2.83–2.70) (2.00–1.95) 1.37–1.35
No. of
reflections
20 580 8945 51 446 80 461
Rmerge (%) 14.3 (77.6) 16.2 (56.4) 18.1 (38.7) 8.6 (57.5)
I/ϬI 10.6 (2.1) 5.2 (2.0) 4.7 (2.1) 8.5 (2.1)
Completeness
(%)
99.5 (100) 85.0 (89.6) 99.6 (99.8) 98.7 (97.1)
Redundancy 5.6 (5.9) 4.4 (4.3) 3.5 (3.6) 5.0 (4.2)
Wilson B
factor (A2)
44.90 51.10 9.94 11.10
Refinement
Rwork/Rfree** 17.89/19.02 19.19/23.41 18.96/22.39 13.73/16.19
No. of atoms
Protein 5711 2977 5711 3089
Ligand 77 50 31 74
Waters 87 3 302 430
Average B-factors (A2)
Protein 47.05 49.89 14.66 12.93
Ligand 54.28 54.83 31.43 24.14
Water 33.85 41.8 20.66 28.16
R.m.s. deviations
Bond lengths
(A)
0.012 0.012 0.013 0.012
Bond angles (°) 1.552 1.587 1.666 1.690
PDB Code 6FBN 6FCB 6FAJ 6G6R
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(occupancy, 1.0) in the active site (Fig. 3A,B). Neither
SAMe or Met are observed in this structure. Even
though the dimerization is not prevented by Arg264
mutation, the absence of an interaction between NH2
and NE atoms of Arg264 and O2G and O3G atoms
of PPNP (Fig. 3C) results in Pc of PPNP not being
observed in the structure, suggesting the importance
of Arg264 in stabilizing triphosphate conformation
for favorable nucleophilic reaction. Arg264 con-
tributes to the stabilization of the dimer interface
through many interactions, especially by forming a
salt bridge with Glu57 of the partner subunit
(Fig. 3C). Mutation of Arg264 results in a decrease
in enzyme stability of both MATa1 and MATa2 as
evident by Tm of wtMATa1, MATa1 (R264H),
wtMATa2, and MATa2 (R264A) which were found
to be 50.3  0.1, 47.4  0.2, 47.2  0.2, and
42.2  0.2 °C, respectively.
Inhibition of substrate turnover by a single
mutation S114A in the gating loop
Two states of the S114A mutant are captured in the
space groups I222 and P22121. The crystal structure of
S114A in the I222 space group has one monomer in
the asymmetric unit. PPNP (1.0) and adenosine (1.0)
are clearly visible in the active site (Fig. 4A). The crys-
tal structure of S114A in the P22121 space group has
two monomers in the asymmetric unit with different
conformations of the gating loop. One monomer has
an active site occupied by PPNP (0.5) and adenosine
(0.75) and shows well-ordered and closed gating loop,
while the other without any ligand in the active site
shows ordered, visible gating loop in the open confor-
mation (Fig. 4B). This is the first time that the gating
loop in its open conformation of human MAT enzyme
family is clearly visible for the main part of the loop
(residues 113–125) (Fig. 4B,D). The same holds true
for archaeal MAT that showed structural rear-
rangement of its gating (flexible) loop (residues 139–
156) in apo- and holo-states of the enzyme structure.
The open resolved gating loops of Thermococcus
kodakarensis MAT in apo-state showed the movement
of the gating loop domain (residues 144–155) from its
closed conformation (residues 142–142), which is
reported in another thermophilic archaeal MAT, Sul-
folobus solfataricus [27, 30] (Fig. 4E,F). The presence
of PPNP and ADO in the S114A structure (Fig. 4C)
indicates that the early step of reaction has taken
place, but the S114A mutant fails to provide the nucle-
ophilic attack of methionine’s sulfur atom against C’5
atom of AMP-PNP, thus unable to produce SAMe.
These observations are consistent with the suggestion
that C-O bond breaking takes place prior to C-S bond
formation at the catalytic transition state of human
Table 2. Crystallographic data collection and refinement statistics
for MATa2 mutants
Mutants S114A S114A R264A
Data collection
Space group P22121 I222 I222
Cell dimensions
a, b, c (A) 62.09, 102.87,
108.17
66.62, 94.68,
116.55
67.14, 94.23,
116.82
a, b, ϒ (A) 90, 90, 90 90, 90, 90 90, 90, 90
Resolution (A) 54.08–1.65 58.28–1.80 58.41–1.70
(last shell) (A) (1.68–1.65) (1.84–1.80) (1.73–1.70)
No. of
reflections
81 704 34 507 40 576
Rmerge (%) 10.8 (56.6) 17.0 (76.6) 12.4 (51.3)
I/ϬI 8.0 (1.9) 5.80 (2.0) 5.9 (1.9)
Completeness
(%)
97.2 (98.4) 99.8 (100) 98.7 (99.8)
Redundancy 5.3 (5.3) 5.3 (5.4) 4.3 (4.1)
Wilson B
factor (A2)
14.90 17.10 12.40
Refinement
Rwork/Rfree** 16.32/19.46 15.10/17.44 16.00/18.42
No. of atoms
Protein 5902 3005 2963
Ligand 78 79 66
Waters 499 224 284
Average B-factors (A2)
Protein 21.72 15.30 15.30
Ligand 27.77 32.78 21.77
Water 27.77 24.81 29.36
R.m.s. deviations
Bond lengths
(A)
0.015 0.014 0.015
Bond angles (°) 1.760 1.670 1.695
PDB Code 6FBP 6FBO 6FCD
Table 3. Summary of the enzymatic activities and ligands found in
the crystallographic structures for MATa2 mutants and wtMATa2
Mutanta
Resolution
(A)
Space
group
Active site
ligands
SAMe
synthesis (%)
Q113A 2.70 P22121 PPNP,
SAMe
75.6  4.5
S114A 1.65 P22121 PPNP, ADO 2.5  0.7
S114A 1.80 I222 PPNP, ADO 2.5  0.7
P115G 2.70 I222 PPNP,
SAMe
111.4  2.8
R264A 1.70 I222 PPi, ADO 4.5  1.4
wtMATa2 1.35 I222 PPNP,
SAMe
100.0
aPPPi hydrolysis rate of all mutants are equivalent to wtMATa2
enzyme; polyphosphatase activity is measured in the presence of
SAMe.
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wtMATa2 [47]. Previously our high-resolution struc-
ture of SAMe+ADO+MET+PPNP wtMATa2 (PDB:
5A1I) had revealed that the Ser114 is the sole residue
in the gating loop that interacts with AMP-PNP via a
water molecule. We propose that Ser114 cooperates
with water molecule in positioning AMP-PNP via its
adenine ring to the proper moiety, which eventually
facilitates enzymatic reaction and SAMe production.
Ser114 also interacts with the neighboring loop
residues (Asp116, Ile117, and Ala118) and stabilize the
helix conformation of the ordered gating loop.
The S114A structure provides information that the
gating loop becomes more ordered in the closed con-
formation as observed by the differences in a helical
initiation and termination residue of the closed
(Pro115-His122) and open (Ile117-Val121) conforma-
tion (Fig. 4B): closed gating loop when active site is
occupied by ligands which is opened when the active
Fig. 2. Oligomeric states of MATa2 R264A mutant and MATa1 R264H mutants. Arg264 mutation of MATa1 and MATa2 Gel filtration
profiles of (A) wtMATa1 R264H and MATa2 R264A mutant; (B) wtMATa2–MATb and MATa2 (R264A)–MATb complexes compared to
wtMATa2 alone. Vertical markers (A,B) represent the elution volumes of molecular standard proteins (GE healthcare) including ferritin (a,
440 kDa), aldolase (b, 158 kDa), conalbumin (c. 75 kDa), ovalbumin (d, 43 kDa), and ribonuclease (e, 13.7 kDa) at 9.25, 12.51, 13.32, 14.90,
and 16.34 mL, respectively. (C) Native (upper panel) and SDS/PAGE (lower panel) gels of the complexes (MATa1-MATbV1, MATa2-
MATbV1, MATa1(R264H)-MATbV1, MATa2(R264A)-MATbV1) and each individual protein (MATa1, MATa2, MATa1(R264H), MATa2(R264A),
MATbV1). For complex formation MATa1 and MATa2 was incubated with both MATbV1 prior to being loaded onto a Superdex 200 10/300.
(D) Crystal structure data were used to calculate SAXS profile (red, blue line) and fitted to SAXS experimental data of MATa2 R264A (black
dot). X-ray scattering profile (black dot) is compared with the tetrameric crystal structure (red line, PDB ID: 5UGH (model); v = 1.65,
C1 = 1.01, C2 = 3.65, Rg = 36.55) and dimeric crystal structure (blue line, PDB ID: 1QM4 (model); v = 27.38, C1 = 1.05, C2 = 4.00,
Rg = 24.73). The experimental data are a better fit in the tetrameric state with the value of Chi (v) = 1.65, compared to v = 27.38 of the
dimer for the original crystallographic structure (upper panel). Retention time of MATa2 R264A elution peak is 7.244 min (lower panel).
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site is empty. In the wtMATa2 (PDB: 5A1I and struc-
ture reported here), two active sites are identical, occu-
pied by substrates or products with gating loop in
closed conformation, sequestration of reactive interme-
diates from escaping into solution. In contrast, in both
S114A and Q113A mutants (see below), only one
active site is occupied by substrate or product suggest-
ing that the gating loop cannot rearrange to the closed
conformation properly during the substrate binding
step, so the reactive intermediates might be able to
leave the enzyme. Two different loop conformations
presented in S114A structure indicate that the loop
has the ability to adopt different conformations when
SAMe formation does not occur.
Production, control, and regulation of SAMe
Given the dramatic effect of Ser114 mutation on the
enzymatic activity of MATa2, mutations of the two
neighboring residues Gln113 and Pro115 were under-
taken and crystallographic structures determined. As
both of these mutants produce a relatively similar
amount of SAMe as the wild-type enzyme, a structural
comparison with wtMATa2 in its apo- and ligand-
bound forms were also undertaken to gain insight into
the control and regulation of catalysis.
The crystal structure of Q113A in the P22121 space
group has two MATa2 monomers in the asymmetric
unit (Fig. 5A). One of the monomers has closed well-
ordered gating loop with full occupancy of SAMe and
PPNP bound in the catalytic site (Fig. 5B). The second
monomer has no ligands in the active site, and its gat-
ing loop is mostly disordered and does not have any
electron density for residues 117–131 (Fig. 5A). In the
wtMATa2, the N and O atoms of substrate methion-
ine’s main chain form hydrogen bonds with the
enzyme at OE1 atom of Glu70 and NE2 atom of
Gln113 of one subunit, respectively, and its N atom
also interacts with OD1 atom of Asp258 belonging to
the dimeric partner subunit. Mutation Q113A does not
affect the binding of Met and SAMe to the active site.
N atom of SAMe forms hydrogen bonds with OE1
atom of Glu70 (2.6 A) and to OD1 atom of Asp258
(2.5 A) and O3 atom of SAMe forms hydrogen bond
with OD2 atom of Asp258 (3.0 A) maintaining the
position of both substrate and product in the active
site (Fig. 5C). The loss of interaction with Met and
ADO due to mutation to Ala is likely to be responsi-
ble for less efficient SAMe production (75% compared
to wtMATa2) but the major role of Gln113 is to sense
the substrate entry and stabilize the closed gating loop
through its interaction with Met, while the entire ori-
entation of the SAMe position is maintained by other
residues in the active site pocket as observed from the
crystal structure.
The different conformations of the gating loop
observed in Q113A and S114A MATa2 mutant struc-
tures clearly shows the importance of these two resi-
dues in catalysis through regulating the gating loop
conformation. These residues sense the presence of
substrate Met and ATP in the active site via the inter-
action of Gln113 with Met and Ser114 with adenine
Fig. 3. Comparison of R264A MATa2 mutant and wild-type structure. (A) Cartoon representation of the crystal structure shows fully
symmetrical crystallographic dimer (gray and blue) with closed gating loop. (B) A close view of R264A mutant active site shows the omit
map contoured around Ala264, PPi and ADO. Fo-Fc omit maps are contoured at the 3 r level and colored in green. (C) A close view of
dimer interface of Arg264 forming a salt bridge with Glu57 of the dimeric subunit and the interactions of PPNP and Arg264 in wtMATa2.
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ring of AMP-PNP, an ATP analog used in the present
study (Fig. 5D). These important interactions of the
gating loop with the substrates drive the rearrange-
ment of the gating loop to its closed conformation.
The crystal structure of P115G MATa2 displays the
closed well-ordered conformation of the gating loop
with full occupancy of SAMe and PPNP in the active
site (Fig. 5E). It does not make any contacts with the
substrate or the product (Fig. 5F). Despite being a
neighboring residue of Ser114, the mutation has no
effect on the overall arrangement of the gating loop
either. SAMe interacts with Glu70 and Gln113 of one
subunit and Asp258 of the partner subunit to maintain
itself in the active site pocket. N and O3 atoms of
SAMe form a H bond with OD1 and OD2 atoms of
Asp258, respectively. The N atom of SAMe also forms
a H bond with the OE1 atom of Glu70, while the O
atom of SAMe interacts with the NE2 atom of
Gln113.
We have also obtained the structure of apo-
wtMATa2 where the gating loops are ordered and visi-
ble in the open conformation (Fig. 6A). The structure
has a dimer in the asymmetric unit and belongs to
P22121 space group similar to S114A mutant. One
active site is dilated because of the gating loop, adja-
cent loop (residues 245–264), and residues 320–328
being oriented in an outward manner to the substrate-
binding cleft, the other subunit features a disordered
Fig. 4. S114A MATa2 mutant structure. (A) I222 crystal form has closed gating loop (red) with PPNP and ADO in the active site. (B) In
P22121 crystal form, one monomer shows well-ordered and closed conformation of the gating loop; ADO and PPNP are bound in the active
site, while the other subunit shows a ordered, visible gating loop in the open conformation and no ligand in the active site. (C) Close views
of S114A mutation site show the omit map contoured around Ala114 and ligands, ADO, and PPNP. (D) Ordered gating loop (residues 113–
125) is in open conformation. Fo-Fc omit maps are contoured at the 3 r level and colored in green. (E) Structural alignments of an archaeal
MAT in open (PDB: 4L4Q, gray) and closed gating loop (PDB: 4L7I, cyan) are shown. Gating loop is shown in red ribbon and all active site
ligands (SAMe and Pi) are shown as sticks. (F) Structural alignments of human MATa2 in open (PDB: 6FAJ, gray) and closed gating loop
(PDB: 5A1I, cyan) are illustrated. Gating loop is shown in red ribbon. SAMe and PPNP are shown as stick.
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open gating loop with a less dilated binding cleft
(Fig. 6B). Structural comparisons between apo-
wtMATa2 and ligand bound (holo) wtMATa2, S114A,
and R264A have revealed that apart from majority
movement in the gating loop region itself, the adjacent
loop and residues 320–328 that contribute to the sub-
strate/product-binding pocket (Fig. 6A,B) of holo-
wtMATa2 and R264A line inward to the active site
pocket, while these substrate-binding clefts of S114A
are oriented outwardly from the active site similarly
found in apo-wtMATa2. These comparisons support
the importance of Ser114 interaction with substrates in
the rearrangement of the gating loop into its closed
conformation and preventing the substrate-binding
pocket residues from moving apart from the active
site, which fails in S114A mutant. Most residues that
are involved in catalysis including Ser247, Arg249
(Fig. 6A,B) have similar conformation in apo- and
holo-wtMATa2, except for Phe250 and Asp258. These
residues move from their original positions in the apo-
wtMATa2 (Fig. 6C). In the holo-state of wtMATa2,
the OG atom of Ser247, O atom of Arg249, and OD1
and OD2 of Asp258 form H bonds with N1 (2.81 A),
N6 (2.90 A), N (2.76 A), and O3 atom (2.70 A) of
SAMe, respectively, while Phe250 interacts with SAMe
through p–p stacking between adenine and aromatic
ring of Phe250 (Fig. 6C). The positions of Glu23,
His29, Lys181, Lys265, Lys285, Lys289, and Asp291
which are involved in the catalysis are preserved in
both apo- and holo-wtMATa2. The dilation of the
substrate-binding pocket found in the MAT
(a2)4(bV2)2 complex is identical to the open site found
in the current apo-wtMATa2, suggesting that this dila-
tion is not the unique property of the complex.
Interaction with MATb and open gating loop in
apo-MATa2
We note that MATb interacts with the catalytic sub-
unit residues that recognize the PPPi of the ATP in
the active site [14] via the helical loop (Fig. 7A,B).
NE2 atom of His323 (MATbV2) interacts with O
atom of Gly273 (MATa2) of the tripolyphosphate
recognition loop (Arg264-Gly273), where the NE atom
Fig. 5. Comparison of Q113A and P115G MATa2 mutant and wild-type structure. (A) Two different conformations of dimeric subunits of
the enzyme are shown. One monomer has a closed gating loop (red) with SAMe and PPNP inside the active site. The other subunit has the
disordered, open gating loop (red) and no ligands in the active site. (B) A close view of Q113A mutant shows the omit map contoured
around Ala113 and products (PPNP and SAMe) in the active site pocket with ordered and closed gating loops (red). Fo-Fc omit maps are
contoured at the 3 r level and colored in green. (C) A close view of SAMe in the active site of Q113A mutant. (D) The interactions of
Gln113 and Ser114 with Met and ADO in wtMATa2. Water is shown as a red sphere. (E) The close view of P115G mutant shows well-
ordered, closed gating loops and the Fo-Fc omit map is colored in green and contoured at the 3 r level around Gly115 and products (SAMe,
PPNP). (F) A close view of SAMe in the active site of P115G mutant.
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of Arg264 (MATa2) interacts with the O1G and O3G
atom of PPNP (Fig. 7B). The present study has found
that the phosphatase activity of the complexes is sig-
nificantly higher than that of the catalytic subunits
alone (Fig. 1B). Triphosphate is a product intermedi-
ate generated from SAMe formation and it has to be
hydrolyzed before being released from the active site
to allow MAT enzyme to regenerate for the next reac-
tion cycle. The underlying mechanism by which the
observed activities of the mutants are recovered by
complex formation is in part facilitated by the pro-
found increase in phosphatase activities of the enzyme
complexes and is consistent with the protein dynamics
study that showed MATa2 ATP-binding region to
undergo allosteric modification upon binding of
MATb [24]. Structural comparison of the wtMATa2
and MATa2b complex revealed that conformation of
the residues in the catalytic site of wtMATa2 is unal-
tered upon complex formation with MATb; however,
several movements of the solvent exposed a-helices are
found in the complex formation. Residues 341–353 are
observed prominently being oriented outward when
compared to those in apo- and holo-oligomeric of
wtMATa2. The MATa2b complex structure shows an
increase in a-helix solvent-exposed area along the
MAT(a2)4 surface when compared to the homo-oligo-
mer of the wild-type (Fig. 7A). Also, the complex sta-
bility of both MATa2bV1 (Tm = 55.2  0.1 °C,
P < 0.001) and MATa2bV2 (Tm = 48.4  0.1 °C) are
significantly increased when compared to catalytic
subunit alone (Tm = 47.2  0.2 °C, P < 0.001). Over-
all active site conformations for both S114A and
R264A mutants are similar to wild-type protein with
0.2 A movements of residues 250–286 away from the
dimer interface in S114A mutant. Apo-S114A mutant
structure is similar to Apo-wtMATa2, both have a
wider open active cleft than in holo-wtMATa2, while
in the MATa2b complex this cleft takes an intermedi-
ate position (between apo and holo). A less dilated
substrate-binding pocket of MATa2b is a result of the
MATb interaction. The local changes in the complex
suggest that MATb insertion modulates the tightness
of the dimer interface (residues 250–286) that com-
prises substrate-binding pocket which could result in
different degrees of the activity recovery for R264A
and S114A mutants.
Recovery of enzymatic activity through chemical
intervention
The search for chemical compounds that effect the
SAMe production of MATa2 enzyme has seen lim-
ited success. A recent study [24] showed that 1-[2-
(dimethylamino) ethyl] quinoline benzodiazepine
derivative (PF-9366) affects the catalysis significantly
and competes with MATb protein by binding in the
interaction region that is used by MATb for complex
formation of MATa2b. PF-9366 binding to Apo-
wtMATa2 causes a closure of the interdimer interface
similar to holo-wtMATa2 structure with the biggest
Fig. 6. Conformational changes between
apo- and ligand-bound wtMATa2. (A) Apo-
wtMATa2 dimer (gray) shows an ordered
and visible gating loop (red) and substrate/
product-binding pocket (yellow and orange).
The interactions of the key residues Gln113,
Ser114, and Pro115 and R264A are shown
in the local surrounding. (B) The surface
view of the substrate-binding clefts of apo-
wtMATa2 (gray) is shown with a gating
loop (red), adjacent loop (245–264, yellow),
and residues 320–328 (orange) (C)
Structural comparison between holo- (blue
stick) and apo- (white stick) wtMATa2
shows SAMe interactions with Ser247,
Arg249, and Asp258 and their positions in
the apo-state.
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movement in domain composed by residues 181–269
(Fig. 8A).
We have undertaken a focused screening of quino-
lone-based compounds (Fig. 8B) on the enzymatic
activities of wtMATa1, wtMATa2, and MATa2
mutants (S114A and R264A). For the mutant enzymes
where the mutation had caused near complete aboli-
tion of SAMe production, the activity is restored by
these quinolone-based compounds to varying degrees
(Fig. 8C). In fact for wtMATa1, the enzymatic activity
doubles with a number of compounds while the SAMe
production of wtMATa2 is marginally reduced by all
of these compounds. In contrast, none of these quino-
lone compounds show any change in the phosphatase
activities of wtMATa1 and wtMATa2 (Fig. 8D), while
the binding of MATb to MATa2 and mutants signifi-
cantly elevates their phosphatase activities. This selec-
tivity of the quinolone compounds for modulating the
SAMe production of the wild-type and disease-causing
mutants offers a clear opportunity for chemical inter-
vention for therapeutic purposes by altering SAMe
levels in the cell.
To gain further insight, we used SCR0915 to study
the effect of a quinolone-based compound on
wtMATa2 and MATa2 R264A mutant (Fig. 9A–D).
In wtMATa2, SCR0915 acts as an inhibitor in the
concentration-dependent manner (Fig. 9A). The inhibi-
tion curve and IC50 of SCR0915 on wtMATa2 are
determined and shown in Fig. 9C. SCR0915 does not
alter the thermal stability of wtMATa2. In contrast,
SCR0915 could recover R264A activity at 0.1–100 lM
(Fig. 9B) and R264A melting temperature increased to
41.48  0.06 °C compared with R264A alone
(39.2  0.07 °C), indicating that SCR0915 increases
the mutant stability (Fig. 9D). The compound behaves
as an allosteric regulator to activate MATa2 when
Met or SAMe are at a low concentration, but it inhi-
bits enzyme activity when Met or SAMe concentra-
tions are high. One possible mechanism is that the
compound renders MATa2 mutant to be more sensi-
tive to SAMe inhibition, which explains why it
decreases the amount of SAMe in wtMATa2, and
increases SAMe production of MATa2 R264A only to
41.23  1.37% relatively to wtMATa2 (Fig. 8C), while
MATb could recover SAMe levels of MATa2 R264A
to the same level found in wild-type (Fig. 1A).
Molecular modeling of SCR0915-binding site
The binding of SCR0915 was explored using Auto-
dock Vina and SwissDock using structures of both
wtMATa2 and MATa2 (R264A). The binding modes
are obtained from both local and blind docking and
the most favorable energies are evaluated based on
Gibbs free energy (ΔG) in Autodock Vina and FullFit-
ness score in SwissDock. The two docking programs
show the best scored positions of SCR0915-binding
site at similar dimeric interface of MATa2 in both
wtMATa2 and MATa2 (R264A). This dimeric inter-
face-binding pocket has been reported to interact with
MATb and PF-9366 compound [14,24]. The best bind-
ing position of SCR0915 using wtMATa2 structure as
a model (PDB, 5A1I) predicted by Autodock vina
(ΔG = 11.4 kcalmol1) and SwissDock (FullFit-
ness = 3486.08 kcalmol1, and ΔG = 7.8 kcalmol1)
are shown in Fig 10A–C. The best binding position of
SCR0915 using MATa2 (R264A) structure as a model
(PDB, 6FCD) predicted by Autodock vina
(ΔG = 10.2 kcalmol1) and SwissDock (FullFit-
ness = 3111.79 kcalmol1, and ΔG = 8.1 kcalmol1)
are shown in Fig 10D–F. PF-9366-binding structure
(PDB, 5UGH) is shown with SCR0915-binding site
(Fig. 10G). Two molecules of PF-9366 bound to
MATa2 dimer (one molecule to one MATa2 monomer),
while one molecule of SCR0915 was predicted to bind
to the dimer (Fig. 10G,H). We test whether SCR0915
could inhibit the formation of MATa2-MATb com-
plexes by using SEC analysis. MATa2 was preincubated
Fig. 7. Structural comparison of MATab complex and homo-oligomeric wtMATa2. (A) An overview of MATa2 (upper) and MATab complex
(lower), PDB id: 4NDN shows enzyme surface with the gating loop colored red, a-helix, b-sheet, and connecting loop are shown in cyan,
purple, and pink, respectively. (B) A close view of MATa2 in MATab complex (pink) and wtMATa2 (pale green) alignment of the structures
shows the helical loop (yellow), residues 264–273, that recognizes the triple phosphate.
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with MATa2 before MATbV1 is introduced into the
solution. We find that SCR0915 partially excludes
MATb from binding to MATa2 (Fig. 10I), confirming
that SCR0915 interaction sites to MATa2 overlap with
the interacting site of MATb.
Conclusion
The gating loop shows distinct behavior during steps
of enzyme catalysis in apo-, PPNP-, SAMe-, Met-, and
ADO-bound structures providing direct evidence by
which the gating loop facilitates the enzyme catalysis.
Functional analysis and crystallographic structures in
the present study elucidate the nonputative role of the
MAT gating loop where the single residue, Ser114, is
involved in catalytic reaction by coordinating the ade-
nine ring of the substrate ATP via a water molecule
and also providing a rigid helix conformation of the
closed gating loop. The observation of the ordered
open conformation of the gating loop for the first time
provides a clear understanding on how it undergoes
structural changes during enzyme catalysis upon sub-
strate binding and product release as observed in
Q113A and S114A mutant structures. The interactions
of the gating loop with substrates drive the rearrange-
ment to the closed conformation. We also provide the
explanation of why Arg264 mutation results in the loss
of the enzymatic activity as found in patients with
Fig. 8. Structural comparison of PF9366-bound structure to holo-wtMATa2 and MATab complex structure and quinolone-based compound
study. (A) PF9366-bound structure (PDB: 5UGH, bright blue), holo-wtMATa2 (PDB: 5A1I, red), and MATab complex structure (PDB: 4NDN,
pale blue) are shown. Domain (181–269) with the biggest shift in helical loop (residues 213–235) is shown as cartoon. PF-9366 is shown as
a blue stick. (B) Quinolone-based compounds used in this study and PF9366 MATa2 inhibitor are shown. (C) Effect of quinolone-based
compounds (10 lM) on SAMe formation of wtMAT and mutants. SAMe formation was analyzed by S-adenosylmethionine ELISA kit (Cell
biolabs). All enzymes were preincubated with methionine before adding ATP to initiate the reactions. (D) Phosphatase activity was
unaffected by any of the chemical compounds. Data are mean  SEM (n = 3). All reactions of enzyme assays were measured at 750 nm.
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hypermethioninemia. The loss in activity results from
the loss of interaction between Arg264 and PPPi moi-
ety at the c-site. We also observed that the phos-
phatase activity and SAMe production involve
different parts of the catalytic pocket of the enzyme as
phosphatase activity is not affected by the pathogenic
mutations where SAMe production is dramatically
decreased. A focused screening of quinolone-based
compound that exploits heterodimeric interface as a
target for chemical intervention, shows selectivity of
the compounds for modulating the SAMe production
of the wild-type and disease-causing mutant interface
(Fig. 11), offering a clear opportunity for therapeutic
solutions. The compounds behave as an allosteric reg-
ulator to activate MATa2 when Met or SAMe are at
low concentrations but inhibits enzyme activity when
Met or SAMe concentrations are high.
Materials and methods
Site-directed mutagenesis
Primers (Q113A mat2A F:CTGGTAGCCTTGGAG
CAAGCGTCACCAGATATTGCTCAA, Q113A mat2A
R: TTGAGCAATATCTGGTGACGCTTGCTCCAAGGC
TACCAG, S114A mat2A F: GTAGCCTTGGAGCAA
CAGGCACCAGATATTGCTCAAGGT, S114A mat2A
R: ACCTTGAGCAATATCTGGTGCCTGTTGCTCCAA
GGCTAC, P115G mat2A F: GCCTTGGAGCAACAGT
CAGGAGATATTGCTCAAGGTGTT, P115G mat2A R:
AACACCTTGAGCAATATCTCCTGACTGTTGCTCCA
AGGC, R264A mat2A F: GATGCTGGTTTGACTG
GAGCGAAAATCATTGTGGACACT, R264A mat2A R:
AGTGTCCACAATGATTTTCGCTCCAGTCAAACCAG
CATC, R264H mat1A F: GATGCGGGTGTCACTGGC
CATAAGATTATTGTGGACACC, R264H mat1A R:
GGTGTCCACAATAATCTTATGGCCAGTGACACCC
GCATC) for site-directed mutagenesis were designed by
using SNAPGENE software (from GSL Biotech; available at
snapgene.com). The desired mutated plasmids were
obtained by using CloneAmp HiFi PCR Premix (Clon-
tech, Mountain View, CA, USA). A total of 12.5 lL of
CloneAmp HiFi PCR Premix was mixed with 7.5 pmol
of each primer, 100 ng of wild-type DNA plasmid, and
adjust volume to 25 lL with autoclaved water. All tubes
were centrifuged shortly and the thermal cycler was pro-
grammed with the following cycling conditions: 10 min
98 °C; 10 s 98 °C; 15 s 55–60 °C; 45 s 72 °C; 10 min
72 °C. Steps 2–4 were repeated 34 times. DNA templates
were removed by adding 1 lL DpnI (NEB, Ipswich, MA,
USA) per 25 lL reaction volume, and the PCR products
were incubated at 37 °C for 2 h. Then, the plasmids were
transformed to Stellartm (Clontech) competent cells.
Transformed cells were plated in selective agar plates and
incubated at 37 °C overnight. A single colony was inocu-
lated to 5 mL of selective media, and incubated at
250 rpm, 37 °C overnight. DNA plasmids were purified
Fig. 9. The effect of SCR0915 on wtMATa2 and MATa2 R264A activity. (A) SCR0915 inhibits wtMATa2 activity in the concentration-
dependent manner (B) SCR0915 recovers SAMe production in R264A mutant. (C) Half-maximal inhibitory concentration of SCR0915 on
wtMATa2 is determined (IC50 = 282.8 nM). IC50 values were calculated from a log([SCR0911]) versus normalized response curve fit using
GRAPHPAD PRISM version 5.00. (D) Thermal shift assay is used to determine R264A stability with and without 1 mM SCR0915 compound. (‘***’
indicates statistical significance at P < 0.001 compared with wtMATa2 alone). Data are mean  SEM (n = 3).
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and sent to Sequencing at GATC biotech, Konstanz,
Germany.
Protein expression and purification of MATa1,
MATa2, MATbV1, and MATbV2
MATa1, MATa2 constructs (pNIC28-Bsa4 plasmid)were
kindly provided by The Structural Genomics Consortium
(SGC, Oxford, UK), MATbV1 and MATbV2 constructs
(pET-28M-SUMO3-GP plasmid) were used in the study.
All MAT proteins were produced in E. coli BL21 (DE3
strain) and grown in Lysogeny broth (LB) with
50 lgmL1 of kanamycin for antibiotics selection. Pro-
tein expression was induced by adding 1 mM of Isopropyl
b-D-1-thiogalactopyranoside (IPTG) at A600 = 0.6–0.8.
Cells were cultured overnight (18 h) at 20 °C. Cell pellets
were resuspended with ice-cold Lysis Buffer (500 mM
NaCl, 5% (v/v) glycerol, 5 mM Imidazole, 10 mM b-ME).
Fig. 10. Molecular modeling of ligand-binding site using Autodock Vina and SwissDock. (A) MATa2 dimeric interface is shown in blue and
yellow ribbon. The best pose of SCR0915 binding site is predicted by Autodock Vina and SwissDock. SCR0915 is shown in green stick
(Autodock Vina) and magenta stick (SwissDock) (B, C) SCR0915 and wtMATa2 interaction profiles obtained by Autodock Vina and
SwissDock are demonstrated, respectively. (D) MATa2 (R264A) dimeric interface is shown in blue and green ribbon. The best pose of
SCR0915 binding site is obtained by Autodock Vina and SwissDock. (E, F) SCR0915 and MATa2 (R264A) interaction profiles obtained from
Autodock Vina and SwissDock are visualized, respectively. Protein–ligand interactions are shown in dashed line with black (H-bond), bule
(halogen bond), pink (hydrophobic interaction: p–p stacking), and orange color (electrostatic interaction) (G) PF-9366-MATa2 structure (PDB,
5UGH) is shown in tetramer with two molecules of PF-9366 (blue stick) in each dimer. The modeling of SCR0915-binding site obtained by
SwissDock (magenta stick) overlaps the PF-9366-binding site. (H) Close-up view of the PF-9366 and SCR0915-binding site in wtMATa2
(PDB, 5UGH). (I) Gel filtration profile of wtMATa2-MATbV1 complexes is shown. MATa2 is preincubated with 10 lM SCR0915 before
forming a complex with MATbV1 (red line). MATa2b complex without SCR0915 intervention is shown (blue line).
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All tubes were placed on ice cell suspension was sonicated
by 15 cycles (30 s on/off cycles). Then the sample was cen-
trifuged at 20 000 g for 40 min. Clear supernatant was col-
lected and load into the His-trap HP column (GE Healthcare,
Chicago, IL, USA) pre-equilibrated with Lysis Buffer. The
column was washed with 10 column volumes of Lysis Buffer
and then by five column volumes of Wash buffer (500 mM
NaCl, 5% (v/v) glycerol, 30 mM Imidazole and 10 mM b-
ME). Then, proteins were eluted with the Elution buffer
(500 mM NaCl, 250 mM Imidazol, 10 mM b-ME). To cleave
the His-tag fromMATa2, eluted proteins were incubated with
Tobacco Etch Virus (TEV) protease in 100 (protein):1 (TEV)
ratio overnight at 4 °C in Dialysis Buffer (25 mM HEPES pH
7.5, 50 mM NaCl and 10 mM b-ME). The SUMO tag was
cleaved from MATbV1 and MATbV2 by incubating with
Sentrin-specific protease 2 (SENP2) in 1500 (protein):1
(SENP2) ratio. Proteins were left at room temperature for an
hour in an orbital shaker and then dialyzed against Dialysis
buffer overnight at 4 °C. All proteins were centrifuged at
4000 g for 30 min and loaded onto an anion-exchange chro-
matography column (HiTrap Q HP, GE Healthcare) pre-equi-
librated with Buffer A (25 mM HEPES pH 7.5, 25 mM NaCl
and 5 mM b-ME). Proteins were eluted by using salt gradient
from 0.05 M to 1 M NaCl (buffer containing Buffer A and
NaCl). Selected fractions of proteins were then concentrated
by using centrifugal concentrator at 10K cut-off and loaded
onto a HiLoad 16/600 Superdex 200 (MATa1/a2) or HiLoad
16/600 Superdex 75 (MATbV1/V2) gel filtration column (GE
healthcare) pre-equilibrated with 25 mM HEPES pH 7.5.
Fractions containing proteins were pooled and stored in 5%
glycerol. Proteins were flash frozen by liquid nitrogen and
stored at 80 °C.
Activity assay
The enzyme activity assay was performed by following
Murray et al. [14]. Briefly, all enzymes (MATa2, MAT
(a2)4(bV1)2 and MAT(a2)4(bV2)2 final concentrations are
50, 25, and 12.5 nM, respectively) were preincubated with
200 lM methionine and reaction buffer (50 mM HEPES pH
7.5, 25 mM MgCl2, 25 mM KCl) for 15 min to equilibrate
the enzyme and substrate methionine. ATP (1 mM) was
added to initiate the reactions and all mixtures were agi-
tated at 1400 rpm (Titramax 100; Heidolph Instruments,
Schwabach, Germany), 37 °C for 10 min. The reactions
were stopped by adding 50 lL of 100 mM EDTA before
measuring SAMe and Pi production. SAMe synthetic activ-
ity was measured as the production of SAMe under the sat-
urating concentration of substrates methionine (200 lM)
and the constant concentration of ATP (1 mM). Phos-
phatase activity of MAT enzyme was measured by detect-
ing inorganic phosphate (Pi) under the presence of SAMe.
Data were expressed as the means  Standard Error of
Mean (SEM). Significance was assessed using a one-way
analysis of variance (ANOVA), followed by Tukey–Kramer
tests using GRAPHPAD PRISM version 5 (GraphPad Software
Inc., San Diego, CA, USA). P-values less than 0.05 were
considered significant.
SAMe formation detection
S-adenosyl-methionine formation was analyzed by S-adeno-
sylmethionine enzyme-linked immunosorbent assay
(ELISA) kit (Cell biolabs, San Diego, CA, USA) following
the manufacturer’s protocol. The measurements were
Fig. 11. The MATb and SCR0915 regulate
MATa2 activity. The MATbV2-binding site is
located at MATa2 dimeric interface and
shown in red box. The compound
(SCR0915) might interact with MATa2 at
the MATb-binding site and behave as an
allosteric regulator to activate MATa2 when
Met or SAMe are at low concentrations,
while inhibiting enzyme activity when Met
or SAMe concentrations are high. SAMe
levels control methylation process of
essential biomolecules (Phospholipids,
proteins, DNA, RNA, etc.) of an organism.
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performed triplicates. Data are the average of the indepen-
dent experiments  SEM.
Phosphatase activity
The detection of inorganic phosphate was modified from
Baginski et al. [48]. One hundred and fifty microliter reac-
tion samples were mixed with 150 lL of 2% Ascorbic acid
in 10% trichloroacetic acid (A-TCA). Fifty microliters of
water was added in each sample, followed by 75 lL of 2%
ammonium molybdate, and 150 lL of 2% (W/V) arsenite–
citrate in 10% TCA. All samples were mixed thoroughly
(vortex) and incubated at room temperature for 20 min.
The samples were measured at 750 nm. Pi quantification
was obtained by using a calibration curve obtained from
various standard KH2PO4 solutions covering a Pi concen-
tration range of 0.125–2.0 lLmL1.
Quinolone-based compounds
The synthesis of quinolone-based compounds has been
described by one of the authors in Biagini et al. [49] and
Charoensutthivarakul et al. [50].
Differential scanning fluorimetry
Differential scanning fluorimetry was performed in a Fast
Optical 96-well reaction plate (Life Technologies, Carlsbad.
CA, USA) using Applied Biosystems StepOnePlusTM Real-
Time PCR instrument (Applied Biosystems, Foster City,
CA, USA). Each well (20 lL) consists of 10 lL of MATa2
proteins (0.2–1.8 mgmL1) diluted in 25 mM HEPES pH
7.5 and 10 lL of 10X Sypro Orange (Life Technologies).
For quinolone-based compound study, 10 lL of MATa2
proteins (3.2 mgmL1) and 1.5 mM of SCR0915 are
diluted in dilution buffer (10 mM HEPES pH 7.5, 500 mM
NaCl, 5% (v/v) glycerol and 0.5 mM TCEP). Fluorescence
intensities were measured from 25 °C to 99 °C with a ramp
rate of 1 °Cmin1. Data were analyzed using MATLAB
executable TmToolTM following TmToolTM Quick Set-Up
Guide (Life technologies). Data are represented as the aver-
age Tm of the independent experiments  SEM (n = 3).
Crystallization and data collection
All MATa2 mutants were eluted as a single peak by size-
exclusion chromatography. Proteins were concentrated to
5.8 mgmL1 and pre-equilibrated with substrates (10 mM
Met and 150 lM AMP-PNP, nonhydrolyzable analog of
ATP) in 50 mM HEPES buffer pH 7.5, 10 mM MgCl2,
50 mM KCl, and 10 mM DTT before crystallization. Crystal
drops containing 1 lL of protein and 1 lL of 100 mM
HEPES pH 6.5 and 30% PEG 600 were equilibrated against
reservoir solution (100 mM HEPES pH 6.5 and 30% PEG
600). Crystals appeared at 25 °C within 1–2 days. Prior to
data collection, crystals were flash frozen in reservoir solu-
tion with additional 20% ethylene glycol. Different datasets
were collected at the I24, I03, and I04-1 beamlines at Dia-
mond Light Source (Oxford, England) and the PROXIMA-1
beamline at SOLEIL synchrotron (Saint-Aubin, France).
Data were integrated by iMosflm [51, 52] and scaled using
Aimless [53]. The initial model of wtMAT2 (PDB: 5A1I) was
from crystals with I222 space group. Molecular replacement
(MOLREP software) [54] is needed for mutant structures with
P22121 space group, while mutants with I222 space group
could be taken straight to restraint refinement using
REFMAC [55]. Model building and restrained refinement
were carried out using coot [56] and REFMAC [55]. Crystal-
lographic data collection and refinement statistics and the
summary of the enzymatic activities and ligands bound in
each structure of MATa2 mutants are shown in Tables 1
and 2.
Small-angle X-ray scattering
Size-exclusion chromatography–small-angle X-ray scatter-
ing (SEC-SAXS) measurements were performed on the
SWING beamline at Synchrotron SOLEIL. An Agilent
BioSEC Advance 300A, 4.6 9 300 mm column equilibrated
with 25 mM HEPES pH 7.5 was used for a gel filtration
step immediately prior to exposure to X-rays. Twenty
microliters of protein at 10 mgmL1 was injected through
an Agilent 1200 HPLC system at a flow rate of
0.3 mLmin1 and column temperature of 15 °C. Exposures
were collected prior to the column void volume, for the
purposes of buffer scattering subtraction, and over the
course of protein elution. Exposures were interspersed for 1
s with a 0.5-s dead-time. Frames were inspected and aver-
aged in Foxtrot and analyzed with Primus. The scattering
data obtained by SEC-SAXS are computed and compared
to the dimeric and tetrameric oligomer of the crystal struc-
tures using FoXS Server [57]. FoXS computes the SAXS
profile from the input crystallographic structure and fits it
onto the experimental profile.
Molecular docking
Both local and blind dockings are carried out using Auto-
dock Vina [58] and SwissDock [59, 60], respectively. Many
binding modes are generated either in a box (local docking)
or in the vicinity of all target cavities (blind docking).
SCR0915 molecule in Tripos Mol2 File Format (.mol2) is
generated using Marvinsketch tool (https://chemaxon.com/
products/marvin). The crystal structure of wtMATa2
(PDB: 5A1I) and MATa2 (R264A) (PDB: 6FCD) which all
ligands are excluded is used as a target protein model.
In Autodock Vina studies, the similar grid parameters
(box center: x = 2.43 A, y = 11.29 A and z = 29.28 A,
box size: x = 29.08 A, y = 67.52 A, z = 59.57 A) are
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determined in both wtMATa2 and MATa2 (R264A) mod-
els. All binding modes are generated in the determined box
with a number of all possible clusters and the most favor-
able energy binding mode is evaluated based on its binding
energy (ΔGbinding: kcalmol1).
In the Swissdock study, the target protein model in PDB
file format and ligand in Mol2 format are uploaded onto a
web browser interface (http://www.swissdock.ch/docking).
Many binding modes are generated in the vicinity of all
target cavities (blind docking). Once the docking processes
are terminated, all possible binding clusters are available to
download and visualized by Viewdock tool in UCSF Chi-
mera suite [61]. The best binding pose is obtained by Gibbs
free energy (ΔG) and FullFitness scores.
The best pose of SCR0915 is selected and combined with
its model. The protein–ligand complex PDB file format is
written by using UCSF Chimera tool. The protein–ligand
interaction profiles are generated and visualized by DS
visualizer (Dassault Systemes BIOVIA, Discovery Studio
Modeling Environment, Release 2017, San Diego: Dassault
Systemes, 2016).
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